Infinity Pharmaceuticals | INFI - Assets


Infinity Pharmaceuticals reported $21.23M in Assets for its fiscal quarter ending in June of 2023.





Assets Change Date
AbbVie USD 136.46B 2.5B Mar/2026
Alterity Therapeutics Limited AUD 37.98M 15.78M Dec/2025
Amgen USD 92.5B 1.92B Mar/2026
AstraZeneca USD 114.02B 59M Mar/2026
Bristol-Myers Squibb USD 86.48B 3.56B Mar/2026
Cipla INR 424.96B 23.32B Mar/2026
Clal Biotechnology ILS 158.39M 24.3M Dec/2023
Compugen USD 156.57M 58.73M Dec/2025
CSL USD 37.9B 1.5B Dec/2025
Eisai JPY 1.45T 37.11B Mar/2026
Eli Lilly USD 116.58B 4.1B Mar/2026
Gilead Sciences USD 56.28B 2.74B Mar/2026
GlaxoSmithKline GBP 62.87B 1.75B Mar/2026
Grifols EUR 23.15B 142.7M Dec/2025
Incyte USD 7.34B 381.14M Mar/2026
Infinity Pharmaceuticals USD 21.23M 8.72M Jun/2023
Ionis Pharmaceuticals USD 3.45B 74M Mar/2026
J&J USD 200.89B 1.68B Mar/2026
Novartis USD 118.53B 7.58B Mar/2026
Pfizer USD 207.62B 542M Mar/2026
Plus Therapeutics USD 19.92M 3.59M Mar/2026
Roche Holding CHF 100.7B 5.94B Dec/2025
TG Therapeutics USD 1.53B 465.58M Mar/2026